RGDechi-hCit: αvβ3 Selective Pro-Apoptotic Peptide as Potential Carrier for Drug Delivery into Melanoma Metastatic Cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RGDechi-hCit: αvβ3 Selective Pro-Apoptotic Peptide as Potential Carrier for Drug Delivery into Melanoma Metastatic Cells
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 9, Pages e106441
Publisher
Public Library of Science (PLoS)
Online
2014-09-24
DOI
10.1371/journal.pone.0106441
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The treatment of glioblastomas: A systematic update on clinical Phase III trials
- (2013) An-an Yin et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- In vitro study of combined cilengitide and radiation treatment in breast cancer cell lines
- (2013) Tim Lautenschlaeger et al. Radiation Oncology
- Integrin Targeted Therapeutics
- (2012) Melissa Millard et al. Theranostics
- Integrin Targeted Delivery of Chemotherapeutics
- (2012) Kai Chen et al. Theranostics
- Cilengitide: an RGD pentapeptide ανβ3 and ανβ5 integrin inhibitor in development for glioblastoma and other malignancies
- (2011) David A Reardon et al. Future Oncology
- Evaluation of the anti-angiogenic properties of the new selective αVβ3 integrin antagonist RGDechiHCit
- (2011) Gaetano Santulli et al. Journal of Translational Medicine
- RAM, an RGDS Analog, Exerts Potent Anti-Melanoma Effects In Vitro and In Vivo
- (2011) Maria Simona Aguzzi et al. PLoS One
- Synthetic strategy for side chain mono-N-alkylation of Fmoc-amino acids promoted by molecular sieves
- (2010) Luca Monfregola et al. AMINO ACIDS
- Intracellular targets of RGDS peptide in melanoma cells
- (2010) Maria Aguzzi et al. Molecular Cancer
- Targeting integrins in malignant glioma
- (2010) Ghazaleh Tabatabai et al. Targeted Oncology
- Integrins
- (2009) Malgorzata Barczyk et al. CELL AND TISSUE RESEARCH
- Imaging of v 3 Expression by a Bifunctional Chimeric RGD Peptide not Cross-Reacting with v 5
- (2009) A. Zannetti et al. CLINICAL CANCER RESEARCH
- Chemotherapy and biologic therapies for melanoma: do they work?
- (2009) Lucia B. Jilaveanu et al. CLINICS IN DERMATOLOGY
- Peptides for Tumour Therapy and Diagnosis: Current Status and Future Directions
- (2009) Laura Zaccaro et al. CURRENT MEDICINAL CHEMISTRY
- Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline
- (2009) Claus Garbe et al. EUROPEAN JOURNAL OF CANCER
- Integrin αvβ3-targeted cancer therapy
- (2008) Zhaofei Liu et al. DRUG DEVELOPMENT RESEARCH
- Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK/src/AKT pathway
- (2008) Leticia Oliveira-Ferrer et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- RGD peptide-induced cell death of chondrocytes and synovial cells
- (2008) Keisuke Matsuki et al. JOURNAL OF ORTHOPAEDIC SCIENCE
- Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis
- (2008) Md Rowshon Alam et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started